DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAMRCSFoundation

Damage-control resuscitation and permissive hypotension

Essential points for quick revision.

!
Resuscitation without control is temporary

Large-volume fluid and normalisation of pressure before haemostasis can increase bleeding, dilution and hypothermia, while under-resuscitation can cause irreversible organ and brain ischaemia.

Action: Control external sources, activate major-haemorrhage support, use warmed blood components and early tranexamic acid, accept restricted volume resuscitation only while appropriate, and expedite operative or endovascular haemostasis with higher perfusion priority in brain or spinal injury.

Synopsis

Use haemostatic, temperature-conscious resuscitation while bleeding remains uncontrolled, understand when restricted pressure targets are unsafe, and link physiology to rapid damage-control intervention.

  • Damage-control resuscitation combines restricted volume before control, haemostatic blood-component support, tranexamic acid, warming, calcium surveillance and rapid anatomical haemostasis.
  • Permissive hypotension is a temporary bleeding-control strategy, not a fixed number or endpoint; judge consciousness, pulses, refill, lactate and response within the local protocol.
  • Do not use a low-pressure strategy indiscriminately in traumatic brain or spinal cord injury, where avoiding hypotension and maintaining perfusion takes priority.

Key red flags

Persistent shock, a transient response or escalating blood requirement means damage-control resuscitation is failing unless definitive haemorrhage control is occurring simultaneously.

Investigation priorities

01
First-line serial blood gasFirst stepFirst line

Track oxygen debt, ventilation and ionised calcium during resuscitation.

02
Preferred viscoelastic assay when availablePreferred

Individualise haemostatic component therapy rapidly.

Management branches

InitialStart damage-control resuscitation

Major bleeding is suspected before anatomical control.

  1. Control external and junctional bleeding, splint fractures and apply a trochanteric pelvic binder when indicated while activating the major-haemorrhage protocol.
  2. Use warmed blood components with minimal crystalloid, administer early tranexamic acid and establish rapid access and monitoring.

Key medicines

Tranexamic acidGive 1 g by intravenous injection over 10 minutes, then infuse 1 g intravenously over the following 8 hours; initiate as soon as possible after injury and within 3 hours.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom